Bio & Pharma
JLK to supply medical AI solutions in Indonesia
The company plans to supply medical AI equipment to the local largest Siloam hospital, including JLK-ICH and JLK-UIA
By Apr 30, 2024 (Gmt+09:00)
1
Min read
Most Read
Deutsche Bank's Korea IB head quits after country head resigns
Macquarie Korea Asset Management confirms two nominees
Hanwha buys S’pore Dyna-Mac’s stake for $73.8 mn from Keppel
Korea's Taeyoung to sell local hotel to speed up debt workout
Meritz leaves door open for an M&A, to stay shareholder friendly
South Korea’s JLK Inc., an AI-based stroke care platform maker, announced on Tuesday that it signed a business agreement with medical consulting firm PT Kind Communication to export medical AI solutions to Indonesia.
Under the agreement, JLK will supply medical AI solutions such as JLK-ICH for detecting brain hemorrhages and JLK-UIA for detecting brain aneurysms to Siloam Hospitals, the largest hospital system in Indonesia.
Siloam Hospitals operates 41 hospitals and 30 clinics across Indonesia.
According to the company, the agreement was made based on a previous business agreement involving the National IT Industry Promotion Agency (NIPA), the Indonesian Ministry of Health, Siloam Hospitals, and PT, which aimed to facilitate the entry of domestic medical AI companies into the Indonesian market.
Write to Yena Kim at yena@hankyung.com
More to Read
-
Bio & PharmaKorea's JLK targets AI-based stroke care market in USJan 10, 2024 (Gmt+09:00)
2 Min read -
Comment 0
LOG IN